Status:
COMPLETED
Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant
Lead Sponsor:
Shire
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy of SPD489 when used as augmentation to an antidepressant in the treatment of major depressive disorder (MDD) as measured by mean change in total Montgomery-Ǻsberg Depression R...
Eligibility Criteria
Inclusion
- Adults aged 18-55 with a primary diagnosis of nonpsychotic MDD
Exclusion
- History of non-response to multiple antidepressants
Key Trial Info
Start Date :
July 30 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 4 2010
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT00905424
Start Date
July 30 2009
End Date
August 4 2010
Last Update
June 14 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmacology Research Institute (PRI)
Newport Beach, California, United States, 92660
2
Affiliated Research Institute
San Diego, California, United States, 92108
3
Florida Clinical Research Center, LLC
Bradenton, Florida, United States, 34208
4
Gulfcoast Clinical Research Center
Fort Myers, Florida, United States, 33912